Latest Industry News

All

FDA Delays Key Drug Decision: Is Trump-Era Budget Cuts Impacting Biotech Innovation?

FDA Delays Key Drug Decision: Is Trump-Era Budget Cuts Impacting Biotech Innovation?

Novavax Stays Optimistic as FDA Requests Additional Studies for COVID Vaccine Approval

Novavax Stays Optimistic as FDA Requests Additional Studies for COVID Vaccine Approval

Vaxart's Next-Gen Covid-19 Vaccine: Major Breakthrough as Stop-Work Order Lifted for Mid-Stage Trials

Vaxart’s Next-Gen Covid-19 Vaccine: Major Breakthrough as Stop-Work Order Lifted for Mid-Stage Trials

Keytruda's Breakthrough: New Hope in Head and Neck Cancer Surgery with Pre- and Post-Operative Use

Keytruda’s Breakthrough: New Hope in Head and Neck Cancer Surgery with Pre- and Post-Operative Use

Promising Breakthrough: Johnson & Johnson’s 'Pretzel' Drug Shows 45% Success in Bladder Cancer Treatment!

Promising Breakthrough: Johnson & Johnson’s ‘Pretzel’ Drug Shows 45% Success in Bladder Cancer Treatment!

Key Earnings Insights: Pharma Giants Navigate Tariff Pressures, Akeso's Promising Data, and a CRISPR Breakthrough

Key Earnings Insights: Pharma Giants Navigate Tariff Pressures, Akeso’s Promising Data, and a CRISPR Breakthrough

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

FDA Delays Key Drug Decision: Is Trump-Era Budget Cuts Impacting Biotech Innovation?

FDA Delays Key Drug Decision: Is Trump-Era Budget Cuts Impacting Biotech Innovation?

Novavax Stays Optimistic as FDA Requests Additional Studies for COVID Vaccine Approval

Novavax Stays Optimistic as FDA Requests Additional Studies for COVID Vaccine Approval

Vaxart's Next-Gen Covid-19 Vaccine: Major Breakthrough as Stop-Work Order Lifted for Mid-Stage Trials

Vaxart’s Next-Gen Covid-19 Vaccine: Major Breakthrough as Stop-Work Order Lifted for Mid-Stage Trials

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA